In patients with DKD and animal models, TGF-β ligands, TGFBRs (TGF-β receptors, and downstream signaling molecules such as Smad2 and Smad3 are highly upregulated or activated in the glomerulus, tubules, and renal interstitium (27, 28). Here, TGFB1 is linked to diabetic kidney disease.